DV
Dividend Vision

GDTC — CytoMed Therapeutics Limited Ordinary Shares

CytoMed Therapeutics Limited Ordinary Shares (GDTC)

Total return is -76.3% over the past 3.3 years, 171.9 points behind SPY at 95.6%. Its deepest 1-year drawdown was 73.1%.

GDTC is an equity fund that provides exposure to CytoMed Therapeutics Limited ordinary shares. As a single-stock fund with limited publicly available data on distribution frequency, yield, and expense ratio, it does not offer the diversification typical of traditional ETFs. This fund structure appeals primarily to investors seeking direct exposure to a specific company rather than those pursuing broad dividend income or cost-efficient portfolio diversification.

GDTC key facts

Asset type
Stock
Asset class
Equity
Inception date
04/13/2023
Last close
$0.95
Market cap
$11,832,835
Average volume
30500.0
Beta
0.021
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.26